BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California.
| Revenue (Most Recent Fiscal Year) | $305.11M |
| Net Income (Most Recent Fiscal Year) | $7.45M |
| PE Ratio (Current Year Earnings Estimate) | 190.08 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.57 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 245.18 |
| Pre-Tax Margin (Trailing 12 Months) | 2.54% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -- |
| Current Ratio (Most Recent Fiscal Quarter) | 11.69 |
| Quick Ratio (Most Recent Fiscal Quarter) | 11.32 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.12 |
| Inventory Turnover (Trailing 12 Months) | 5.53 |
| Book Value per Share (Most Recent Fiscal Quarter) | $10.48 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.11 |
| Earnings per Share (Most Recent Fiscal Year) | $0.14 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 45.97M |
| Free Float | -- |
| Market Capitalization | $3.65B |
| Average Volume (Last 20 Days) | 0.31M |
| Beta (Past 60 Months) | -- |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |